Gantz says Israel to start human trials of coronavirus vaccine in September The defense minister says the phase 3 clinical trial is set to begin after the Jewish High Holidays at Institute for Biological Research in Ness Ziona; there are currently 4 potential vaccines in the world that reached human trials
Yoav Zitun|
Published: 08.06.20 , 15:27
Defense Minister Benny Gantz said on Thursday an Israeli research institute will begin human trials on a potential coronavirus vaccine after the Jewish High Holidays in September.
Gantz visited the Israel Institute for Biological Research in Ness Ziona earlier in the day, where the director of the institute, Prof. Shmuel Shapira, updated him on the progress in the development of the potential vaccine.
"The successful preliminary trials raise much hope," said Gantz. "The next step, as agreed, is the beginning of human trials after the High Holidays. This will be done in coordination with the Health Ministry and according to all medical safety requirements." Prof. Shapira praised the defense and health ministries as well as the Prime Minister's Office's cooperation with the institute and said although they are yet to conduct the safety and efficacy trials, Israel already has "a product in hand".
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.